Target intelligence / Profile preview

Pathogen-associated carbohydrate moieties recognized by surfactant protein D (SP-D ligands)

Target
SP-D ligands
Molecular classification
Other, Carbohydrate, Glycan, Lipopolysaccharide
01

Overview

Pathogen-associated carbohydrate moieties recognized by surfactant protein D (SP-D) represent a diverse class of microbial surface molecules, including lipopolysaccharides (LPS), lipoteichoic acids (LTA), and various terminal glycans. These moieties serve as pathogen-associated molecular patterns (PAMPs) that are specifically identified by the C-type lectin domain of SP-D, a key component of the innate immune system (Nayak et al., 2012, PMID: 22703241). Upon binding, SP-D facilitates the aggregation, opsonization, and subsequent clearance of pathogens such as bacteria, viruses, and fungi by alveolar macrophages (Watson et al., 2019, PMID: 31110321). In addition to direct antimicrobial activity, the interaction between SP-D and these carbohydrate targets modulates inflammatory signaling pathways, helping to maintain pulmonary homeostasis (Gardai et al., 2003, PMID: 14560035). Therapeutic strategies often involve the use of recombinant human SP-D or its fragments to target these moieties in conditions like neonatal respiratory distress syndrome, chronic obstructive pulmonary disease (COPD), and various respiratory infections (UniProt P35247).

Other names
SP-D ligandsPathogen-associated molecular patterns recognized by SP-DMicrobial surface glycansSurfactant protein D carbohydrate targets
02

Mechanism of action

Binding to terminal sugars (e.g., mannose, fucose, glucose) on pathogen surfaces via the C-terminal carbohydrate recognition domain (CRD) in a calcium-dependent manner, leading to pathogen neutralization and enhanced phagocytosis.

03

Biological functions

Immune responseOpsonizationPathogen recognitionInflammation modulationOther
04

Disease associations

InfectionInflammationRespiratory distress syndromeChronic obstructive pulmonary diseaseOther
05

Safety considerations

Potential for pro-inflammatory effects depending on protein orientationImmunogenicity of recombinant protein fragmentsOff-target binding to host glycans
06

Interacting drugs

Recombinant human surfactant protein D (rhSP-D)

1 more in the full profile.

07

Biomarkers

Serum surfactant protein D (SFTPD) levelBronchoalveolar lavage fluid (BALF) SP-D concentration

Beyond the preview

Go deeper on Pathogen-associated carbohydrate moieties recognized by surfactant protein D (SP-D ligands).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogen-associated carbohydrate moieties recognized by surfactant protein D (SP-D ligands).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call